Allergan Aesthetics received FDA approval for Skinvive by Juvéderm for the improvement of neck appearance, marking the second cleared indication for the product line. Skinvive, a smooth, cohesive HA formulation designed for superficial dermal placement, was previously approved for chin augmentation. The neck approval broadens the injectable's clinical utility in a high-visibility zone where practitioners increasingly seek alternatives to traditional volumizers and neuromodulators.
Injectables
FDA Approves Skinvive by Juvéderm for Neck Lines — New Indication Expands Allergan's Dermal Filler Portfolio
Allergan Aesthetics wins clearance for Skinvive in neck appearance improvement, adding a second indication to its HA-based injectable platform.
Skinvive now carries two FDA-cleared indications, expanding Allergan's injectable footprint in aesthetic anatomy.
For practice economics, this expansion matters: it creates a new revenue stream in an anatomical area where patient demand is rising but clinical options remain limited. Skinvive's mechanism—a smooth HA gel optimized for superficial placement—positions it differently from traditional cross-linked fillers like Juvéderm Ultra or Volbella, which are designed for deeper dermal or subdermal injection. Practices already carrying Allergan's portfolio can add this indication without new inventory complexity, though training on proper neck-specific injection technique will be essential to avoid common pitfalls like Tyndall effect or product migration.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.